rs2306862

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_002335.4(LRP5):​c.2220C>T​(p.Asn740Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.149 in 1,613,820 control chromosomes in the GnomAD database, including 19,522 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1352 hom., cov: 31)
Exomes 𝑓: 0.15 ( 18170 hom. )

Consequence

LRP5
NM_002335.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: 0.276

Publications

63 publications found
Variant links:
Genes affected
LRP5 (HGNC:6697): (LDL receptor related protein 5) This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
LRP5 Gene-Disease associations (from GenCC):
  • bone mineral density quantitative trait locus 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • exudative vitreoretinopathy 4
    Inheritance: AD, SD, Unknown Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • osteoporosis-pseudoglioma syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant osteosclerosis, Worth type
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • polycystic liver disease 4 with or without kidney cysts
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • autosomal dominant osteopetrosis 1
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • exudative vitreoretinopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hyperostosis corticalis generalisata
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteosclerosis-developmental delay-craniosynostosis syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • polycystic liver disease 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 11-68410042-C-T is Benign according to our data. Variant chr11-68410042-C-T is described in ClinVar as Benign. ClinVar VariationId is 193639.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.276 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.189 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP5NM_002335.4 linkc.2220C>T p.Asn740Asn synonymous_variant Exon 10 of 23 ENST00000294304.12 NP_002326.2 O75197

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP5ENST00000294304.12 linkc.2220C>T p.Asn740Asn synonymous_variant Exon 10 of 23 1 NM_002335.4 ENSP00000294304.6 O75197
LRP5ENST00000529993.5 linkn.*826C>T non_coding_transcript_exon_variant Exon 10 of 23 1 ENSP00000436652.1 E9PHY1
LRP5ENST00000529993.5 linkn.*826C>T 3_prime_UTR_variant Exon 10 of 23 1 ENSP00000436652.1 E9PHY1
LRP5ENST00000528714.1 linkn.14C>T non_coding_transcript_exon_variant Exon 1 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.118
AC:
18011
AN:
152022
Hom.:
1352
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0468
Gnomad AMI
AF:
0.462
Gnomad AMR
AF:
0.160
Gnomad ASJ
AF:
0.142
Gnomad EAS
AF:
0.200
Gnomad SAS
AF:
0.0841
Gnomad FIN
AF:
0.0429
Gnomad MID
AF:
0.152
Gnomad NFE
AF:
0.154
Gnomad OTH
AF:
0.142
GnomAD2 exomes
AF:
0.136
AC:
34275
AN:
251274
AF XY:
0.133
show subpopulations
Gnomad AFR exome
AF:
0.0464
Gnomad AMR exome
AF:
0.193
Gnomad ASJ exome
AF:
0.150
Gnomad EAS exome
AF:
0.199
Gnomad FIN exome
AF:
0.0472
Gnomad NFE exome
AF:
0.152
Gnomad OTH exome
AF:
0.143
GnomAD4 exome
AF:
0.152
AC:
222751
AN:
1461680
Hom.:
18170
Cov.:
37
AF XY:
0.150
AC XY:
109128
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.0389
AC:
1304
AN:
33480
American (AMR)
AF:
0.188
AC:
8413
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.154
AC:
4015
AN:
26134
East Asian (EAS)
AF:
0.231
AC:
9162
AN:
39700
South Asian (SAS)
AF:
0.0815
AC:
7032
AN:
86258
European-Finnish (FIN)
AF:
0.0503
AC:
2684
AN:
53372
Middle Eastern (MID)
AF:
0.135
AC:
776
AN:
5768
European-Non Finnish (NFE)
AF:
0.163
AC:
180784
AN:
1111862
Other (OTH)
AF:
0.142
AC:
8581
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
10942
21884
32826
43768
54710
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6498
12996
19494
25992
32490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.118
AC:
18015
AN:
152140
Hom.:
1352
Cov.:
31
AF XY:
0.114
AC XY:
8461
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.0467
AC:
1941
AN:
41536
American (AMR)
AF:
0.160
AC:
2445
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.142
AC:
493
AN:
3468
East Asian (EAS)
AF:
0.199
AC:
1029
AN:
5158
South Asian (SAS)
AF:
0.0843
AC:
406
AN:
4814
European-Finnish (FIN)
AF:
0.0429
AC:
455
AN:
10600
Middle Eastern (MID)
AF:
0.156
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
0.154
AC:
10479
AN:
67980
Other (OTH)
AF:
0.143
AC:
302
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
773
1546
2319
3092
3865
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.148
Hom.:
6891
Bravo
AF:
0.132
Asia WGS
AF:
0.125
AC:
436
AN:
3478
EpiCase
AF:
0.161
EpiControl
AF:
0.158

ClinVar

Significance: Benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22511589, 17505772, 16115379) -

May 24, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Osteogenesis imperfecta Benign:1
Jul 18, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Increased bone mineral density Benign:1
Mar 19, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bone mineral density quantitative trait locus 1 Other:1
Jan 01, 2004
OMIM
Significance:Affects
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
8.6
DANN
Benign
0.84
PhyloP100
0.28
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2306862; hg19: chr11-68177510; COSMIC: COSV53718329; COSMIC: COSV53718329; API